Company Filing History:
4 out of 2,119 
2 out of 924 
Years Active: 2018-2022
Title: Ignacio Melgar-Asensio: Innovator in Biomedical Research
Introduction
Ignacio Melgar-Asensio is a prominent inventor based in Chicago, IL (US). He has made significant contributions to the field of biomedical research, particularly in the development of novel therapeutic agents. With a total of 4 patents, his work focuses on innovative solutions for treating various diseases.
Latest Patents
One of his latest patents involves modified pigment epithelium-derived factor (PEDF) peptides and their applications for treating neovascular diseases, inflammatory diseases, cancer, and for cytoprotection. This patent discloses modified PEDF peptides, particulate carrier prodrugs, and pharmaceutical compositions that can be utilized to treat conditions responsive to anti-angiogenic, anti-tumorigenic, anti-fibrotic agents, chemotherapy-protecting agents, and immune-stimulating agents. Another significant patent pertains to biodegradable nanocarriers that possess a net positive surface charge, designed for sustained local drug release. These nanocarriers, which are covalently attached to peptides, can be administered for localized and sustained delivery of therapeutic drugs.
Career Highlights
Ignacio has worked with esteemed institutions such as Northwestern University and the University of Nebraska. His research has been pivotal in advancing the understanding and treatment of complex medical conditions.
Collaborations
He has collaborated with notable colleagues, including Jack Henkin and Olga Volpert, contributing to a rich environment of innovation and discovery.
Conclusion
Ignacio Melgar-Asensio's work exemplifies the intersection of innovation and healthcare, showcasing his commitment to developing effective treatments for challenging diseases. His contributions continue to impact the biomedical field significantly.